MCET Stock UPDATES Multicell Techs Inc (MCET) 0.0007 08/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Multicell Techs Inc (MCET) 0.0007 $MCET

MultiCell Technologies files patent applications for MCT-485
M2 - Fri Mar 21, 7:01AM CDT
US-based biopharmaceutical company MultiCell Technologies (OTC BB:MCET) revealed on Thursday that it has submitted applications for additional US and international patents covering MCT-485 and its composition of matter, biological targets, mechanism of action and methods and formulations for therapeutic use.

Groupon and SF-Marin Food Bank to Present "One Groupon One Meal" Campaign; MultiCell Technologies Files Patent Applications
ACCESSWIRE - Thu Mar 20, 11:27PM CDT
Walter Energy, Inc. (NYSE: WLT) - For an in-depth report on Walter Energy, Inc. follow: www.BullTrends.com/stockquote/WLT

MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer
PR Newswire - Thu Mar 20, 7:39AM CDT
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has filed additional U.S. and international patent applications covering MCT-485 and its composition of matter, biological targets, mechanism of action, and methods and formulations for therapeutic use.

eLayaway Inc. Share Price Soars 75 Percent
ACCESSWIRE - Mon Mar 17, 8:50AM CDT
March 17, 2014 / eLayaway Inc. (OTCQB: ELAY) share volume skyrocketed Mar. 14, with 1,232,461,409 shares changing hands, nearly nine times its three-month average volume of 138,035,702 shares.

MultiCell Technologies Seeks Patent for Cancer-Fighting Technology
ACCESSWIRE - Tue Mar 04, 9:03AM CST
MultiCell Technologies Inc. (OTCQB: MCET) stock volume soared Mar. 3, with 41,190,256 shares changing hands, significantly higher than its three-month average volume of 30,444,778 shares.

MultiCell Technologies Inc files patent application for new class of RNA Therapeutics, VSRNAs
M2 - Thu Jan 16, 4:40AM CST
Biopharmaceutical company MultiCell Technologies Inc (OTC BB:MCET.OB) reported on Wednesday the submission of a US provisional patent application covering the composition of matter, biological targets, mechanism of action, methods and formulations to achieve targeted tumor cell death.

MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
PR Newswire - Wed Jan 15, 7:39AM CST
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a U.S. provisional patent application concerning composition of matter, biological targets, mechanism of action, methods and formulations to achieve targeted tumor cell death.

OTC Daily Alert Stock Watch - MultiCell Technologies, Inc. (OTCQB: MCET)
WorldStockWire - Thu Sep 05, 4:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
PR Newswire - Tue Aug 06, 7:00AM CDT
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle therapeutics for the treatment of liver cancer. MCT-485 is a noncoding double stranded micro RNA (miRNA) which has demonstrated oncolytic and immune stimulating activity in in vitro models of hepatocellular carcinoma.

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
PR Newswire - Thu May 16, 7:00AM CDT
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the filing of a U.S. patent application concerning methods and formulations to achieve targeted tumor cell death. MCT-485 is a noncoding double stranded micro RNA (miRNA) which has demonstrated oncolytic and immune stimulating activity in in vitro models of hepatocellular carcinoma.

MultiCell Technologies and Federal National Mortgage Association Review: (OTCQB: MCET), (OTCQB: FNMA)
ACCESSWIRE-TNW - Sun Mar 03, 4:29PM CST
New York (March 3rd, 2013) - MultiCell Technologies, Inc. (OTCQB: MCET) Files SEC form 10-K, Annual Report.

Medical Marijuana and MultiCell Technologies News: (OTC Pink: MJNA), (OTCQB: MCET)
ACCESSWIRE-TNW - Fri Mar 01, 1:21AM CST
New York (March 1st, 2013) - Medical Marijuana, Inc. (OTC Pink: MJNA) a leading cannabis and hemp industry innovator provided a comprehensive update to shareholders on the state of the medical cannabis and hemp industry. Many legislative actions have occurred, particularly since the November elections, which are providing significant positive momentum in our rapidly expanding markets.

China Teletech Holding and MultiCell Technologies Trend Analysis Reports: (OTCQB: CNCT), (OTCQB: MCET)
ACCESSWIRE-TNW - Tue Feb 26, 1:58AM CST
New York (February 26th, 2013) - China Teletech Holding, Inc. (OTCQB: CNCT) last traded at $0.215, down $-0.069 or 24.30%. The stock has a 52 week range of $0.00 - $0.47. In the last session the stock traded a volume of 26.58M versus a 30 day average of 843,675.

AMR Corp Announcement & MultiCell Technologies Bullish Momentum: (OTCQB: AAMRQ), (OTCQB: MCET)
ACCESSWIRE-TNW - Wed Feb 20, 12:06AM CST
New York (February 20th, 2013) - AMR Corporation (OTCQB: AAMRQ), the parent company of American Airlines, Inc., and US Airways Group, Inc. (LCC) announced last week that the boards of directors of both companies have unanimously approved a definitive merger agreement under which the companies will combine to create a premier global carrier, which will have an implied combined equity value of approximately $11 billion based on the price of US Airways' stock as of February 13, 2013.

MultiCell Technologies presents abstract at 2012 ASCB Meeting
M2 - Thu Dec 27, 8:39AM CST
MultiCell Technologies Inc (OTCBB: MCET), a clinical-stage biopharmaceutical company, said on Wednesday that at the 2012 American Society for Cell Biology (ASCB) Annual Meeting, being held in San Francisco, California, Simona Bot, MD on Tuesday presented preclinical research results in an abstract titled 'Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma'.

MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting
PR Newswire - Wed Dec 26, 7:00AM CST
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual Meeting in San Francisco, CA, on Tuesday, December 18. Simona Bot, M.D. presented preclinical research results in an abstract titled "Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma."




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading